Ranbaxy ties up with UK-based Microbia
Thursday, 27 February 2003, 20:30 IST
Printer Print Email Email
CAMBRIDGE: Ranbaxy Laboratories said on Wednesday that it has entered into a tie-up with biotechnology company Microbia to develop improved, higher-yielding bio-manufacturing processes using precision engineering technology. "Ranbaxy has chosen Microbia to apply its pioneering precision engineering technologies to our processes because of its potential to significantly advance our capabilities," Ranbaxy's senior vice-president, Pushpinder Bindra, was quoted as saying by news agencies. "We hope this will be the first in a series of product collaborations with Microbia focused on advancing our bio-manufacturing operations with cutting-edge biotechnologies." he told agencies. Precision engineering is a comprehensive technology that targets the physiological control networks in fungi and bacteria to harness their metabolic potential. The technology is a systems-based approach to engineering the regulatory circuitry of microbial mini-factories used in industrial-scale production of pharmaceuticals and fine chemicals. Benefits of precision engineering include reduced process improvement cycle time and the ability to increase production without having to expand bio-manufacturing facilities. "We are pleased that Ranbaxy, one of the world's leading pharmaceutical manufacturers, has selected Microbia as a partner," said Microbia CEO, Peter Hecht.
Source: IANS
siliconindia